Shots:
The CHMP has recommended Opdivo + Pt-based CT as neoadj. followed by Opdivo alone as adj. treatment of adults with resectable NSCLC at high risk of recurrence & PD-L1 expression ≥1%. If approved, EC’s decision would be valid in all 30 EEA states
The P-III (CheckMate-77T) study assessed neoadj. Opdivo + CT, followed by surgery…
